JP2014208655A5 - - Google Patents

Download PDF

Info

Publication number
JP2014208655A5
JP2014208655A5 JP2014111987A JP2014111987A JP2014208655A5 JP 2014208655 A5 JP2014208655 A5 JP 2014208655A5 JP 2014111987 A JP2014111987 A JP 2014111987A JP 2014111987 A JP2014111987 A JP 2014111987A JP 2014208655 A5 JP2014208655 A5 JP 2014208655A5
Authority
JP
Japan
Prior art keywords
inner core
water
bead
pharmaceutical formulation
pharmaceutical ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014111987A
Other languages
English (en)
Japanese (ja)
Other versions
JP5876896B2 (ja
JP2014208655A (ja
Filing date
Publication date
Priority claimed from US11/701,178 external-priority patent/US20080187579A1/en
Application filed filed Critical
Publication of JP2014208655A publication Critical patent/JP2014208655A/ja
Publication of JP2014208655A5 publication Critical patent/JP2014208655A5/ja
Application granted granted Critical
Publication of JP5876896B2 publication Critical patent/JP5876896B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014111987A 2007-02-01 2014-05-30 持続放出性剤形 Expired - Fee Related JP5876896B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/701,178 2007-02-01
US11/701,178 US20080187579A1 (en) 2007-02-01 2007-02-01 Extended-release dosage form

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009548269A Division JP5868571B2 (ja) 2007-02-01 2008-01-24 持続放出性剤形

Publications (3)

Publication Number Publication Date
JP2014208655A JP2014208655A (ja) 2014-11-06
JP2014208655A5 true JP2014208655A5 (https=) 2015-10-29
JP5876896B2 JP5876896B2 (ja) 2016-03-02

Family

ID=39496215

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009548269A Expired - Fee Related JP5868571B2 (ja) 2007-02-01 2008-01-24 持続放出性剤形
JP2014111987A Expired - Fee Related JP5876896B2 (ja) 2007-02-01 2014-05-30 持続放出性剤形

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009548269A Expired - Fee Related JP5868571B2 (ja) 2007-02-01 2008-01-24 持続放出性剤形

Country Status (11)

Country Link
US (3) US20080187579A1 (https=)
EP (1) EP2114382A1 (https=)
JP (2) JP5868571B2 (https=)
KR (1) KR20090109117A (https=)
CN (1) CN101646422A (https=)
AU (1) AU2008211318B2 (https=)
BR (1) BRPI0807001A2 (https=)
CA (1) CA2676650C (https=)
MX (1) MX341015B (https=)
NZ (1) NZ578656A (https=)
WO (1) WO2008094440A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
US20120207825A1 (en) * 2009-09-17 2012-08-16 Sunilendu Bhushan Roy Pharmaceutical compositions for reducing alcohol-induced dose dumping
BR112015000320B1 (pt) 2012-07-12 2023-03-07 SpecGx LLC Composições farmacêuticas dissuasivas de abuso e seu processo de preparação
CN104587472B (zh) * 2014-12-31 2017-12-15 广东国方医药科技有限公司 一种含纳米SiO2的包衣剂及其制备方法
ES3008933T3 (en) 2015-09-29 2025-03-25 Merz Pharmaceuticals Llc Sustained release compositions of 4-aminopyridine
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
JP6902043B2 (ja) * 2016-02-11 2021-07-14 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． フマル酸ジメチルを含む医薬ビーズ製剤
US10406336B2 (en) 2016-08-03 2019-09-10 Neil S. Davey Adjustable rate drug delivery implantable device
CN114288273B (zh) * 2022-02-11 2022-10-18 桂林华信制药有限公司 一种盐酸文拉法辛缓释胶囊及其生产工艺
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4587118A (en) * 1981-07-15 1986-05-06 Key Pharmaceuticals, Inc. Dry sustained release theophylline oral formulation
US4556678A (en) * 1982-06-24 1985-12-03 Key Pharmaceuticals, Inc. Sustained release propranolol tablet
PH18946A (en) * 1983-04-21 1985-11-14 Elan Corp Plc Controlled absorption pharmaceutical composition
DE3581428D1 (de) * 1984-06-13 1991-02-28 Roehm Gmbh Verfahren zum ueberziehen von arzneiformen.
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
US5026559A (en) * 1989-04-03 1991-06-25 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5683719A (en) * 1990-11-22 1997-11-04 British Technology Group Limited Controlled release compositions
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
DE19504832A1 (de) * 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
IT1289160B1 (it) * 1997-01-08 1998-09-29 Jagotec Ag Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di
WO2000018500A1 (de) * 1998-09-24 2000-04-06 Glatt Systemtechnik Dresden Gmbh Einrichtung zur herstellung eines schüttfähigen produktes und verfahren zur anwendung der einrichtung
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6500454B1 (en) * 2001-10-04 2002-12-31 Eurand Pharmaceuticals Ltd. Timed, sustained release systems for propranolol
US9358214B2 (en) * 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US7401157B2 (en) * 2002-07-30 2008-07-15 Brocade Communications Systems, Inc. Combining separate infiniband subnets into virtual subnets
US6780003B2 (en) * 2002-08-02 2004-08-24 Mold-Masters Limited Removable heater for a hot runner nozzle
GB0222612D0 (en) * 2002-09-30 2002-11-06 Univ Gent Controlled delivery system for bioactive substances
US9107804B2 (en) * 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride

Similar Documents

Publication Publication Date Title
JP2014208655A5 (https=)
JP6815358B2 (ja) 時限パルス放出システム
JP2010518002A5 (https=)
US8486452B2 (en) Stabilized tolterodine tartrate formulations
JP5876896B2 (ja) 持続放出性剤形
KR20050086409A (ko) 약학 조성물
US11020354B2 (en) Formulations of n-acetylcysteine and uses thereof
US10213389B2 (en) Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
JP2012528799A (ja) 徐放製剤
EP2374460A1 (en) Pulsed-release sildenafil composition and method for preparing said composition
WO2008023390A2 (en) Modified release pharmaceutical composition of bupropion hydrochloride
US10258577B2 (en) Multilayer solid pharmaceutical dosage forms
JP5941117B2 (ja) 徐放製剤
US10835497B2 (en) Rivastigmine-containing sustained-release pharmaceutical composition
WO2013158638A1 (en) Stable dosage forms of skeletal muscle relaxants with extended release coating
US20080193524A1 (en) Extended Release Venlafaxine Compositions
US20060099261A1 (en) Methods and formulations for making controlled release oral dosage form
TW201609196A (zh) 控制釋放製劑及其製備方法
AU2013273835B2 (en) Timed, pulsatile release systems
JP2005510449A (ja) 改良型制御放出経口剤形
WO2007117314A2 (en) Bupropion controlled release formulations and methods of making
HK1108116B (en) Timed, pulsatile release systems